Skip to content
Screener

Collegium Pharmaceutical, Inc. COLL Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$3.17M+11.3%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$3.55M+57.6%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
Organon logo
OrganonOGN
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
MapLight Therapeutics, Inc. logo
MapLight Therapeutics, Inc.MPLT

Other financials

Income statement

See full
Revenue$199.9M+6.3%
Gross profit$110.3M+1.8%
Operating income$3.7M-89.5%
Net income-$15.1M-226%
EPS (diluted)-$0.46-235%

Balance sheet

See full
Cash & equivalents$150.4M+8.8%
Total debt$5.0M-19.8%
Total equity$311.9M+34.3%
Total assets$2.1B+34.1%

Cash flow

See full
Operating cash flow$71.3M-1.5%
CapEx$496.0K+663%
Free cash flow$70.8M-2.1%

Valuation

See full
Market cap$882.2M-22.5%
Enterprise value$736.79M-26.8%
P/E18.4×-13.0×
P/S1.1×-0.5×

Profitability

See full
Gross margin60%+3.3pp
Operating margin19.5%+1.1pp
Net margin5.9%+0.8pp
FCF margin40.6%+10.8pp

Returns & leverage

See full
Return on equity17.6%+1.4pp
Debt / equity0.0×
Current ratio-0.2×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:34 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053851
Line itemJune 30,2026December 31,2025
Intangible assets, net1,186,084669,510
Restricted cash1,0601,056
Deferred tax assets120,774112,539
Other noncurrent assets15,23720,193
Goodwill190,177145,925
Total assets$2,135,790$1,656,834
Liabilities and shareholders’ equity
Current liabilities

Item 1. Condensed Consolidated Financial Statements (Unaudited).

FAQ

What is Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets?
Collegium Pharmaceutical, Inc. (COLL) reported deferred tax assets and other non-current assets of $15.24M in Q2 2026.
How has Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets increased by 296.3% year-over-year, from $3.85M to $15.24M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets has grown at a 177.4% compound annual growth rate (CAGR), from $123K to $20.19M.
What does deferred tax assets and other non-current assets mean?
Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Ask your AI about Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude